Vonoprazan Fumarate

Product Description

Product name:  Vonoprazan Fumarate

Alias: Vonaprazan; 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine2-butenedioate (Vonoprazan); 1-[5-(2-(2-fluorophenyl)-1-pyridinylsulfonyl)-1H-pyrrole-3-methanamine2-butenedioate; 1-[5-(2-(2-(2-fluorophenyl)-1-pyridinyl)-1-(2-fluorophenyl)-1-pyridinylsulfonyl)-1H-pyrrole-3-methanamine2-butenedioate fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine; AK-438; Vonaprazan(TAK-438); vonoprazan(tak-438). Vonoprazanfumarate(TAK-438);vonoprazan(tak-438)1260141-27-2

CAS No.: 881681-01-2 (126141-27-2)

Molecular Formula: C21H20FN3O6S

Molecular weight: 461.4634032

EINECS No.: 250-635-4

Properties: white powder

Storage condition: Store at -20°C

Solubility: Dimethyl sulfoxide: 50 mg/mL (108.35 mM)

Form: Solid

Color: white to off-white
*Patented product for research and register use only

Shandong Chenghui Shuangda Pharmaceutical

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Contract Research Organisation
Generic APIs producer
Intermediates Manufacturer
Specifications
  • CAS Registry Number
    126141-27-2

Shandong Chenghui Shuangda Pharmaceutical

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Contract Research Organisation
Generic APIs producer
Intermediates Manufacturer

More Products from Shandong Chenghui Shuangda Pharmaceutical (4)

  • Dapagliflozin

    Product Dapagliflozin

    Product name:  Dapagliflozin propanediol monohydrateSynonyms: (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOLCOMPOUNDWITH(S)-POPANE-1,2,3,4,5-(HYDROXYMETHYL)TETRAHYDRO PROPANE-1,2-DIOL(1:1)HYDRATE;BMS512148(2S)-1,2-propanediol;CS-1307;Dapaglifloz...
  • Finerenone

    Product Finerenone

    Product name: Finerenone
    Alias: Finerenone (BAY94-8862); (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide; (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide; BAY94-8862; BAY948862; 1,6-Naphthyridine-3-...
  • Letermovir

    Product Letermovir


    Product name: Letermovir

    alias: Letemovir; Lemovir; Letemovir; (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid; Letemovir Standard 005; Letemovir; Letemovir-letemovir; Letemovir-letemovir Letermovir
    ...
  • Resmetirom

    Product Resmetirom


    product name: Resmetirom

    Alias:  MGL-3196; 920509-32-6; VIA-3196; 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5- dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile; MGL 3196; Resmetirom [USAN]; MGL3196; RE0V0T1ES0

    CAS No. 920509-32-6
    ...

Shandong Chenghui Shuangda Pharmaceutical resources (4)

  • News Tetracaine HCl API Granted CEP by EDQM

    We are proud to announce that our pharmaceutical ingredient Tetracaine Hydrochloride has been granted the Certificate of Suitability to the European Pharmacopoeia (CEP) by the European Directorate for the Quality of Medicines (EDQM) on August 20, 2025. This marks a significant milestone as we become the first company in China and one of only three global manufacturers to hold this certification for this critical local anesthetic.

  • Brochure About us

    Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates , CDMO/CRO/OEM, and Technology Transfer of Finished Formulations. With 23 years of production experience, the company operates 6 GMP-compliant workshops, achieving a monthly capacity of 100 tons to meet cGMP requirements. Currently, the factory has registered 21 APIs in NMPA, filed 4 US-DMFs, and applied for 9 CEPs, while successfully passing audits by MFDS, US FDA, and global customers.

  • News Warm congratulations to our API Articaine Hydrochloride for obtaining European CEP certificate.

    On 3 January 2025, our API Articaine Hydrochloride obtained the Certificate of Suitability for European Pharmacopoeia (CEP Certificate) issued by the European Directorate for the Quality of Medicines (EDQM). This is the third CEP certificate for our company, and we are the first company in China (9 companies in the world) to obtain the CEP certificate for Articaine Hydrochloride. 
  • Brochure Product List

    The main production and R & D varieties of local anesthesia, antiviral drugs, cardiovascular and cerebral vascular system, antitumor drugs, digestive drugs, diabetes, veterinary drugs, CDMO products.